Please wait...
About This Project
This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae before founding MicroSynbiotiX. We were partially successful in expressing proinsulin. We were successful in genetically modifying a strain of microalgae to express recombinant proteins (GFP), fish vaccines, and we even began fish vaccine trials with our first candidate product. Fish vaccines are our priority now, but we will revisit insulin and human therapeutics soon!

Browse Other Projects on Experiment
Related Projects
Could non-tuberculous mycobacteria infections explain the high mortality rates among TB patients in Kilifi, Kenya?
Mortality rate is significantly higher among clinically diagnosed Tuberculosis (TB) patients than the ones...
Shutting down cancer’s recycling system with exosome-based therapy
Pancreatic cancer is one of the deadliest cancers because its cells survive by recycling their own components...
Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis
Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...


